| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.76B | 4.26B | 3.12B | 4.05B | 4.42B | 3.12B |
| Gross Profit | 1.63B | 1.41B | 895.54M | 1.04B | 1.17B | 765.31M |
| EBITDA | 1.37B | 1.20B | 762.46M | 840.03M | 967.44M | 587.07M |
| Net Income | 941.38M | 782.42M | 479.97M | 579.19M | 667.40M | 391.95M |
Balance Sheet | ||||||
| Total Assets | 4.39B | 4.25B | 3.63B | 3.51B | 3.51B | 2.71B |
| Cash, Cash Equivalents and Short-Term Investments | 1.08B | 1.08B | 1.11B | 977.57M | 570.93M | 430.12M |
| Total Debt | 4.44M | 2.34M | 4.09M | 3.16M | 24.84M | 3.29M |
| Total Liabilities | 1.03B | 1.12B | 930.65M | 980.47M | 1.29B | 950.61M |
| Stockholders Equity | 3.36B | 3.13B | 2.70B | 2.53B | 2.22B | 1.76B |
Cash Flow | ||||||
| Free Cash Flow | 629.84M | 307.98M | 417.83M | 709.28M | 332.21M | 201.63M |
| Operating Cash Flow | 654.93M | 352.91M | 505.81M | 763.40M | 429.51M | 300.77M |
| Investing Cash Flow | -452.99M | -281.26M | -154.79M | -383.28M | -117.31M | 30.19M |
| Financing Cash Flow | -496.26M | -359.59M | -311.59M | -296.98M | -186.88M | -105.86M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | HK$14.65B | 5.46 | 28.97% | 3.40% | 32.27% | 59.22% | |
78 Outperform | HK$8.67B | 10.00 | 10.93% | 1.57% | -13.95% | -13.61% | |
73 Outperform | HK$16.38B | 12.66 | 13.39% | 3.23% | 2.87% | 17.03% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | HK$14.87B | 20.10 | 8.92% | 1.37% | 35.32% | 24.24% | |
60 Neutral | HK$8.43B | 13.12 | 9.65% | 8.66% | 28.34% | ― | |
58 Neutral | HK$10.10B | 7.99 | 8.82% | 2.50% | 11.18% | 46.57% |